EUVIMEDEUVIMED entdecken
Crossref

Prognostic Modeling and Treatment Analysis in Primary Central Nervous System Lymphoma: A Retrospective SEER Study

Cong Xu

International Journal of Applied Science and Research · 2026 · 09 (01) · 33-41

DOI: 10.56293/ijasr.2026.6904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Applied Science and Research, 2026. Verfasst von Cong Xu.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary central nervous system lymphoma (PCNSL) is a rare and aggressive malignancy with no established standard of care. Patients with PCNSL have a poor prognosis, and corresponding clinical research is limited.

Objective

Using the US SEER database, this study aimed to investigate prognostic factors and construct an individualized prognostic prediction model for PCNSL.

Methods

We enrolled 680 patients with PCNSL and randomly divided them into training and validation cohorts. Univariate and multivariate Cox regression analyses were performed to identify independent prognostic factors, which were then used to construct nomogram models for predicting 1-, 2-, and 3-year overall survival. The model's discriminatory ability, accuracy, and clinical utility were evaluated using the concordance index (C-index), area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA).

Results

Age, chemotherapy, tumor size, and total gross resection (TGR) were identified as independent prognostic factors. The nomogram demonstrated satisfactory predictive performance in both the training and validation cohorts, with C-indices of 0.699 (95% CI, 0.660–0.737) and 0.733 (95% CI, 0.681–0.785), respectively. Survival analysis showed that surgery combined with chemotherapy significantly improved patient prognosis.

Conclusion

This study successfully developed and validated an effective prognostic nomogram for PCNSL, providing a practical tool for individualized prognosis assessment. The results support the combination of surgical resection and chemotherapy as a potential treatment strategy for selected patients with PCNSL.

Zitieren

APA

Xu, C. (2026). Prognostic Modeling and Treatment Analysis in Primary Central Nervous System Lymphoma: A Retrospective SEER Study. International Journal of Applied Science and Research, 09(01), 33-41. https://doi.org/10.56293/ijasr.2026.6904

Vancouver

Xu C. Prognostic Modeling and Treatment Analysis in Primary Central Nervous System Lymphoma: A Retrospective SEER Study. International Journal of Applied Science and Research. 2026;09(01):33-41. doi:10.56293/ijasr.2026.6904

BibTeX
@article{Xu2026,
  author = {Xu, Cong},
  title = {Prognostic Modeling and Treatment Analysis in Primary Central Nervous System Lymphoma: A Retrospective SEER Study},
  journal = {International Journal of Applied Science and Research},
  year = {2026},
  volume = {09},
  number = {01},
  pages = {33--41},
  doi = {10.56293/ijasr.2026.6904}
}
Kostenlos starten →